Health tech in­vestors out­line in­vest­ment pri­or­i­ties in AI

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) 

Ven­ture cap­i­tal, pri­vate and non-prof­it in­vestors who spoke at a pan­el in New York this week laid out their in­vest­ment pri­or­i­ties in health tech com­pa­nies that use AI, say­ing they’re in­ter­est­ed in how ar­ti­fi­cial in­tel­li­gence can im­prove be­hav­ioral health and drug de­vel­op­ment.

An­dreessen Horowitz in­vest­ment part­ner Daisy Wolf told the au­di­ence of a pan­el at Cor­nell Tech’s Health­Next Sum­mit on Tues­day that she be­lieves AI is go­ing to dri­ve drug dis­cov­ery and health di­ag­no­sis so that peo­ple can have a doc­tor in their pock­ets. AI can al­so save clin­i­cians time and boost ef­fi­cien­cy by get­ting rid of frus­trat­ing minu­ti­ae in health­care, she added.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER